Browse by Journal Title

Article

Cancerostatic octadecylpiperidinoylphosphate liposomes: effect of composition on uptake by and toxicity to J774 mouse macrophage cells and MT1 breast cancer cells in vitro.
Zeisig, R. and Stahn, R. and Teppke, A.D. and Arndt, D.
Anti-Cancer Drug Design 16 (1): 19-26. 1 January 2001

Role of crown-like side chains in the biological activity of substituted-phenoxazone drugs.
Karawajew, L. and Glibin, E.N. and Maleev, V.Y. and Czerwony, G. and Doerken, B. and Davies, D.B. and Veselkov, A.N.
Anti-Cancer Drug Design 15 : 331-338. 1 January 2000

Liposome-encapsulated superparamagnetic iron oxide particles as markers in an MRI-guided search for tumor-specific drug carriers.
Paeuser, S. and Reszka, R. and Wagner, S. and Wolf, K.J. and Buhr, H.J. and Berger, G.
Anti-Cancer Drug Design 12 : 125-135. 1 January 1997

Interference of new alkylphospholipid analogues with mitogenic signal transduction.
Maly, K. and Ueberall, F. and Schubert, C. and Kindler, E. and Stekar, J. and Brachwitz, H. and Grunicke, H.
Anti-Cancer Drug Design 10 : 411-425. 1 January 1995

Potential suitability of Na+/K+ -transporting ATPase in pre-screens for anti-cancer agents.
Repke, K.R.H. and Schoen, R. and Megges, R. and Weiland, J. and Nissen, E. and Matthes, E.
Anti-Cancer Drug Design 10 : 177-187. 1 January 1995